Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov record for the KarXT schizophrenia extension study is displayed with its study design, participant criteria, locations, treatment plan, and safety and efficacy measures.SummaryDifference59%

- Check12 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the existing 403 error page. The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check54 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, replacing the details with a standard error screen. This indicates that access to the record is blocked on the site.SummaryDifference17%

- Check61 days agoChange DetectedThe study page now includes the topic Schizophrenia and related topics MedlinePlus Genetics, and the site revision changed from v3.6.6 to v3.7.0.SummaryDifference0.2%

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.